Literature DB >> 22442497

Cardiac-specific knockout of ET(A) receptor mitigates low ambient temperature-induced cardiac hypertrophy and contractile dysfunction.

Yingmei Zhang1, Linlin Li, Yinan Hua, Jennifer M Nunn, Feng Dong, Masashi Yanagisawa, Jun Ren.   

Abstract

Cold exposure is associated with oxidative stress and cardiac dysfunction. The endothelin (ET) system, which plays a key role in myocardial homeostasis, may participate in cold exposure-induced cardiovascular dysfunction. This study was designed to examine the role of ET-1 in cold stress-induced cardiac geometric and contractile responses. Wild-type (WT) and ET(A) receptor knockout (ETAKO) mice were assigned to normal or cold exposure (4°C) environment for 2 and 5 weeks prior to evaluation of cardiac geometry, contractile, and intracellular Ca(2+) properties. Levels of the temperature sensor transient receptor potential vanilloid (TRPV1), mitochondrial proteins for biogenesis and oxidative phosphorylation, including UCP2, HSP90, and PGC1α were evaluated. Cold stress triggered cardiac hypertrophy, depressed myocardial contractile capacity, including fractional shortening, peak shortening, and maximal velocity of shortening/relengthening, reduced intracellular Ca(2+) release, prolonged intracellular Ca(2+) decay and relengthening duration, generation of ROS and superoxide, as well as apoptosis, the effects of which were blunted by ETAKO. Western blotting revealed downregulated TRPV1 and PGC1α as well as upregulated UCP2 and activation of GSK3β, GATA4, and CREB in cold-stressed WT mouse hearts, which were obliterated by ETAKO. Levels of HSP90, an essential regulator for thermotolerance, were unchanged. The TRPV1 agonist SA13353 attenuated whereas TRPV1 antagonist capsazepine mimicked cold stress- or ET-1-induced cardiac anomalies. The GSK3β inhibitor SB216763 ablated cold stress-induced cardiac contractile (but not remodeling) changes and ET-1-induced TRPV1 downregulation. These data suggest that ETAKO protects against cold exposure-induced cardiac remodeling and dysfunction mediated through TRPV1 and mitochondrial function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22442497      PMCID: PMC3612005          DOI: 10.1093/jmcb/mjs002

Source DB:  PubMed          Journal:  J Mol Cell Biol        ISSN: 1759-4685            Impact factor:   6.216


  50 in total

Review 1.  The intrarenal endothelin system and hypertension.

Authors:  Z A Abassi; S Ellahham; J Winaver; A Hoffman
Journal:  News Physiol Sci       Date:  2001-08

2.  Effect of ambient temperature on cardiovascular parameters in rats and mice: a comparative approach.

Authors:  Steven J Swoap; J Michael Overton; Graham Garber
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-04-15       Impact factor: 3.619

3.  Cold exposure and winter mortality from ischaemic heart disease, cerebrovascular disease, respiratory disease, and all causes in warm and cold regions of Europe. The Eurowinter Group.

Authors: 
Journal:  Lancet       Date:  1997-05-10       Impact factor: 79.321

4.  Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT).

Authors:  Thomas F Lüscher; Frank Enseleit; Richard Pacher; Veselin Mitrovic; Matthias R Schulze; Roland Willenbrock; Rainer Dietz; Valentin Rousson; David Hürlimann; Sebastian Philipp; Thomas Notter; Georg Noll; Frank Ruschitzka
Journal:  Circulation       Date:  2002-11-19       Impact factor: 29.690

Review 5.  Cold--an underrated risk factor for health.

Authors:  James B Mercer
Journal:  Environ Res       Date:  2003-05       Impact factor: 6.498

6.  AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase.

Authors:  Jamie R Privratsky; Loren E Wold; James R Sowers; Mark T Quinn; Jun Ren
Journal:  Hypertension       Date:  2003-07-07       Impact factor: 10.190

7.  Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes.

Authors:  Fang-Ping Xu; Min-Sheng Chen; Yan-Zhen Wang; Quan Yi; Shu-Bing Lin; Alex F Chen; Jian-Dong Luo
Journal:  Circulation       Date:  2004-08-16       Impact factor: 29.690

8.  Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore.

Authors:  Magdalena Juhaszova; Dmitry B Zorov; Suhn-Hee Kim; Salvatore Pepe; Qin Fu; Kenneth W Fishbein; Bruce D Ziman; Su Wang; Kirsti Ytrehus; Christopher L Antos; Eric N Olson; Steven J Sollott
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

9.  Cardiomyocyte-specific endothelin A receptor knockout mice have normal cardiac function and an unaltered hypertrophic response to angiotensin II and isoproterenol.

Authors:  Rafal M Kedzierski; Paul A Grayburn; Yaz Y Kisanuki; Clay S Williams; Robert E Hammer; James A Richardson; Micheal D Schneider; Masashi Yanagisawa
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

10.  IGF-1 deficiency resists cardiac hypertrophy and myocardial contractile dysfunction: role of microRNA-1 and microRNA-133a.

Authors:  Yinan Hua; Yingmei Zhang; Jun Ren
Journal:  J Cell Mol Med       Date:  2012-01       Impact factor: 5.310

View more
  19 in total

Review 1.  Cardiovascular response to thermoregulatory challenges.

Authors:  Cuiqing Liu; Zubin Yavar; Qinghua Sun
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-02       Impact factor: 4.733

2.  Mitochondrial aldehyde dehydrogenase 2 accentuates aging-induced cardiac remodeling and contractile dysfunction: role of AMPK, Sirt1, and mitochondrial function.

Authors:  Yingmei Zhang; Shou-Ling Mi; Nan Hu; Thomas A Doser; Aijun Sun; Junbo Ge; Jun Ren
Journal:  Free Radic Biol Med       Date:  2014-03-24       Impact factor: 7.376

3.  Inhibition of CYP2E1 attenuates chronic alcohol intake-induced myocardial contractile dysfunction and apoptosis.

Authors:  Rong-Huai Zhang; Jian-Yuan Gao; Hai-Tao Guo; Glenda I Scott; Anna R Eason; Xiao-Ming Wang; Jun Ren
Journal:  Biochim Biophys Acta       Date:  2012-09-02

Review 4.  Chronic heart failure: Ca(2+), catabolism, and catastrophic cell death.

Authors:  Geoffrey W Cho; Francisco Altamirano; Joseph A Hill
Journal:  Biochim Biophys Acta       Date:  2016-01-13

5.  Expression of the oxygen-sensitive transcription factor subunit HIF-1α in patients suffering from secondary Raynaud syndrome.

Authors:  Lukas Andreas Heger; Mark Kerber; Marcus Hortmann; Samuel Robinson; Maximilian Mauler; Daniela Stallmann; Daniel Duerschmied; Christoph Bode; Christoph Hehrlein; Ingo Ahrens
Journal:  Acta Pharmacol Sin       Date:  2018-07-10       Impact factor: 6.150

6.  Identification of Cardiac Expression Pattern of Transient Receptor Potential Vanilloid Type 1 (TRPV1) Receptor using a Transgenic Reporter Mouse Model.

Authors:  Juan Hong; Amanda M Lisco; Tara L Rudebush; Li Yu; Lie Gao; Oliver Kitzerow; Irving H Zucker; Han-Jun Wang
Journal:  Neurosci Lett       Date:  2020-08-22       Impact factor: 3.046

7.  Role of TRPV1 in the Differentiation of Mouse Embryonic Stem Cells into Cardiomyocytes.

Authors:  Yan Qi; Zenghua Qi; Zhichao Li; Chun-Kit Wong; Chun So; Iek-Chi Lo; Yu Huang; Xiaoqiang Yao; Suk-Ying Tsang
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

Review 8.  Endothelin.

Authors:  Anthony P Davenport; Kelly A Hyndman; Neeraj Dhaun; Christopher Southan; Donald E Kohan; Jennifer S Pollock; David M Pollock; David J Webb; Janet J Maguire
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

Review 9.  Does Transient Receptor Potential Vanilloid Type 1 Alleviate or Aggravate Pathological Myocardial Hypertrophy?

Authors:  Qiqi Yan; Jun Tang; Xin Zhang; Liuyang Wu; Yunyi Xu; Lihong Wang
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

10.  Heavy metal scavenger metallothionein mitigates deep hypothermia-induced myocardial contractile anomalies: role of autophagy.

Authors:  Shasha Jiang; Rui Guo; Yingmei Zhang; Yunzeng Zou; Jun Ren
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-11-06       Impact factor: 5.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.